U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.675C>G (p.Ile225Met) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jan 14, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000657901.3

Allele description [Variation Report for NM_000162.5(GCK):c.675C>G (p.Ile225Met)]

NM_000162.5(GCK):c.675C>G (p.Ile225Met)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.675C>G (p.Ile225Met)
HGVS:
  • NC_000007.14:g.44149764G>C
  • NG_008847.2:g.53407C>G
  • NM_000162.5:c.675C>GMANE SELECT
  • NM_001354800.1:c.675C>G
  • NM_033507.3:c.678C>G
  • NM_033508.3:c.672C>G
  • NP_000153.1:p.Ile225Met
  • NP_001341729.1:p.Ile225Met
  • NP_277042.1:p.Ile226Met
  • NP_277043.1:p.Ile224Met
  • LRG_1074t1:c.675C>G
  • LRG_1074t2:c.678C>G
  • LRG_1074:g.53407C>G
  • LRG_1074p1:p.Ile225Met
  • LRG_1074p2:p.Ile226Met
  • NC_000007.13:g.44189363G>C
  • NM_000162.3:c.675C>G
Protein change:
I224M
Links:
dbSNP: rs772754004
NCBI 1000 Genomes Browser:
rs772754004
Molecular consequence:
  • NM_000162.5:c.675C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.675C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.678C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.672C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000779666GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(May 15, 2018)
germlineclinical testing

Citation Link,

SCV004295166Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 14, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.

Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F, Toni S, Cherubini V, Guazzarotti L, Sulli N, Matschinsky FM, Lorini R, Iafusco D, Barbetti F; Diabetes Study Group of the Italian Society of Paediatic Endocrinology and Diabetes (SIEDP)..

Diabetologia. 2001 Jul;44(7):898-905.

PubMed [citation]
PMID:
11508276

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience.

Marucci A, Di Paola R, Rutigliano I, Fini G, Pezzilli S, Menzaghi C, Trischitta V.

Acta Diabetol. 2023 Jan;60(1):131-135. doi: 10.1007/s00592-022-01982-0. Epub 2022 Oct 13. No abstract available. Erratum in: Acta Diabetol. 2023 Mar;60(3):459. doi: 10.1007/s00592-023-02035-w.

PubMed [citation]
PMID:
36227502
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV000779666.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The I225M missense variant in the GCK gene has been reported previously in association with MODY (Massa et al., 2001; Beer et al., 2012). Functional studies report that I225M demonstrates an inactivating effect on enzyme activity (Beer et al., 2012). The variant is not observed in large population cohorts (Lek et al., 2016). The variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, in-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Missense variants in nearby residues (G223S/R/V, M224R/T, V226M/L/E, G227R/S/C) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this to be a pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004295166.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 225 of the GCK protein (p.Ile225Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of maturity onset diabetes of the young (PMID: 11508276, 22611063, 36227502). ClinVar contains an entry for this variant (Variation ID: 546098). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GCK protein function. Experimental studies have shown that this missense change affects GCK function (PMID: 22611063). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024